Podcasts about Xerostomia

Oral care implications of sleep disorders are multifaceted. Dental professionals are increasingly vital in identifying and supporting treatment for sleep disorders. Dr. Radfar shares with host Matt Crespin, the keys to the successful integration of sleep medicine into his dental practice. He bridges the gap with insights, treatment implications for oral health, and practical tools to help you support and advocate for those in your care who suffer from sleep disorders. This episode is generously sponsored by Aquoral.  

Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren's syndrome and what's on the horizon for future therapeutic options.Topics include:Challenges in Sjogren's Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren's syndrome diagnosis to patients unfamiliar with it and challenges in addressing the disease's varied symptomsPatient Education and Communication: Strategies to prevent overwhelming patients during early visits and effective ways to address misconceptionsDiagnostic Challenges and Misunderstandings: Differences between clinical and research criteria for diagnosis and the importance of understanding eachUse of Ultrasound and Biopsy in Diagnosis: Benefits and limitations of ultrasound and biopsies in diagnosing Sjogren's syndromeMultidisciplinary Care Barriers: Challenges in coordinating care among specialists such as ophthalmologists, dentists, and rheumatologistsSymptomatic vs Disease-Modifying Treatments: Strategies for managing symptoms vs addressing the underlying disease with medicationsLong-term Medication and Risks: Considerations when prescribing long-term medications and immunosuppressive therapiesResearch and Emerging Therapies: Developments in Sjogren's syndrome research, including promising medications in clinical trialsGuideline Development and Patient Reassurance: The role of professional guidelines in shaping care and providing patients with reassurancePolypharmacy and Medication Reconciliation: The importance of pharmacist involvement in managing complex medication regimens for older patients Faculty:Elizabeth Kircher, DNPR. Hal Scofield, MDMember/Professor, Arthritis & Clinical ImmunologyOklahoma Medical Research FoundationProfessor, Department of Medicine, College of MedicineUniversity of Oklahoma Health Sciences CenterAssociate Chief of Staff for ResearchOklahoma City US Department of Veterans Affairs Medical CenterOklahoma City, OklahomaLink to full program:https://bit.ly/3YKpsOE

A recent pilot study finds help for radiation induced xerostomia.  Listen as Kayla Marks tells us how she was involved and what the positive results were.

Xerostomia is a big deal, in our world. But what is saliva? Let's take it from the top. In this episode, we dive into all things saliva – how much of it we produce, what it is made of, where it is realized, how is saliva triggered, and what causes dry mouth. #1 dental hygiene boards review:

Our patients present with different symptoms. Sometimes we catch them during a particularly acute episode of dry mouth and sometimes we don't... but what about all the times in between? Should we tailor our care based on the severity of xerostomia? Tom Viola chimes in with his opinion! Be sure to check out what Tom Viola is up to by visiting Tomviola.com or email him - Tom@Tomviola.com Our partners on this episode Aquoral - Www.aquoralspray.com  

Our patients present with different symptoms. Sometimes we catch them during a particularly acute episode of dry mouth and sometimes we don't... but what about all the times in between? Should we tailor our care based on the severity of xerostomia? Tom Viola chimes in with his opinion! Be sure to check out what Tom Viola is up to by visiting Tomviola.com or email him - Tom@Tomviola.com Our partners on this episode Aquoral - Www.aquoralspray.com  

We know the effects of Xerostomia on the oral environment but what about beyond the mouth? How does that change the risk for systemic diseases? Machell Hudson-Hoover is here to answer this! Machell@rdhhealth integrativedentalcoaching.com

We know the effects of Xerostomia on the oral environment but what about beyond the mouth? How does that change the risk for systemic diseases? Machell Hudson-Hoover is here to answer this! Machell@rdhhealth integrativedentalcoaching.com

Understanding and Managing Xerostomia By Spring Hatfield, RDH, BSPH Original article published on Today's RDH: https://www.todaysrdh.com/understanding-and-managing-xerostomia/ Need CE? Start earning CE credits today at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Kara RDH on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Kara RDH on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/kara_rdh/⁠⁠⁠⁠⁠

Download the Volley.FM app for more short daily shows!

Xerostomia affects nearly one in three adults in the US. Its systemic impacts are being critically evaluated, and of great interest are the resulting digestive problems implicated by xerostomia conditions. Katrina M. Sanders, MEd, BSDH, RDH, RF   Read Article HERE: https://www.rdhmag.com/patient-care/article/14295855/spit-it-out-an-overview-of-xerostomia-and-digestive-disorders 

A new research paper was published in Aging (Aging-US) Volume 15, Issue 7, entitled, “Effect of deferoxamine and ferrostatin-1 on salivary gland dysfunction in ovariectomized rats.” Xerostomia can be defined as a subjective sensation associated with reduction of lubrication and dehydration of the oral mucosa. Xerostomia is known to be common in elderly people, especially women, and its prevalence is thought to range from 5.5% to 46%. The mechanism underlying xerostomia after menopause has not yet been fully elucidated. In this new study, researchers Yong-Il Cheon, Ji Min Kim, Sung-Chan Shin, Hyung-Sik Kim, Jin-Choon Lee, Gi Cheol Park, Eui-Suk Sung, Minhyung Lee, and Byung-Joo Lee from Pusan National University and Sungkyunkwan University School of Medicine aimed to investigate the mechanism of xerostomia and the effect of the ferroptosis inhibitors deferoxamine (DFO) and ferrostatin-1 (FER) on salivary gland dysfunction in a postmenopausal animal model. “Recently, it was reported that ferroptosis in the salivary gland may be related to the xerostomia that occurs after menopause [30]. However, no studies to date have used anti-ferroptosis drugs to investigate the mechanisms underlying postmenopausal salivary gland dysfunction.” Twenty-four female Sprague–Dawley rats were randomly divided into four groups: a SHAM group (n = 6, sham-operated rats), an OVX group (n = 6, ovariectomized rats), an FER group (n = 6, ovariectomized rats injected intraperitoneally with FER), and a DFO group (n = 6, ovariectomized rats injected intraperitoneally with DFO). GPX4 activity, iron accumulation, lipid peroxidation, inflammation, fibrosis, and salivary gland function were analyzed. Recovery of GPX4 activity and a decrease in iron accumulation and cytosolic MDA + HAE were observed in the DFO group. In addition, collagen I, collagen III, TGF-β, IL-6, TNF-α, and TGF-β levels were decreased in the DFO group compared to the OVX group. Recovery of GPX4 activity and the morphology of mitochondria, and reduction of cytosolic MDA + HAE were also observed in the FER group. In addition, decreased expression of inflammatory cytokines and fibrosis markers and increased expression of AQP5 were observed in both the DFO and FER groups. Postmenopausal salivary gland dysfunction is associated with ferroptosis. This is the first study to investigate the effect of ferroptosis inhibitors (DFO and FER) on the salivary glands of ovariectomized rats. DFO and FER are considered promising treatments for postmenopausal xerostomia. “In the absence of a standard treatment for postmenopausal dry mouth, this study is expected to be helpful in understanding the mechanism of postmenopausal salivary gland dysfunction and developing a treatment for postmenopausal dry mouth.” DOI: https://doi.org/10.18632/aging.204641 Corresponding author - Byung-Joo Lee - voicelee@pusan.ac.kr Keywords - aging, menopause, ferroptosis, xerostomia, deferoxamine, ferrostatin-1 About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Visit our website at https://www.Aging-US.com​​ and connect with us: SoundCloud - https://soundcloud.com/Aging-Us Facebook - https://www.facebook.com/AgingUS/ Twitter - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ MEDIA@IMPACTJOURNALS.COM

On this week's episode of The Red Light Report, I unveil BioLight's newest product, the Glow! I detail why the Glow was developed, what makes it special and why it is significantly different than any other handheld red light therapy device on the market. More importantly, I cover one photobiomodulation research article in detail on a topic that I constantly get questions about: cancer. One of the amazing features of red light therapy is that, according to the research, there are zero contraindications for implementing it for a given health condition; that includes cancer. Of course, that comes with the caveat that one should not directly irradiate the site of an active cancer, but can safely treat other parts of the body. And that is not necessarily because irradiating the active cancer site would lead to negative consequences (in some research it has, in others it has actually been beneficial), rather we simply do not know enough to confidently provide guidance on how to best yield red light therapy efficaciously. Said another way, better safe than sorry.With all of that being said, this WALT (World Association for Photobiomodulation Therapy; the "L" used to stand for Laser) paper provides some clarification on the topic of red light therapy and cancer; basically, highlighting what we do and don't know.  At the very least, this provides guide rails, much needed expert perspective on a delicate topic and informs us where we stand in the landscape of red light therapy and cancer. I also have a couple of impromptu rabbit holes I go down, one that includes how many red light therapy companies are inflating their light irradiance as a marketing tactic.With every piece of research we unearth, we only learn more about the amazing healing frequencies of red and near-infrared light. As always, light up your health and enjoy! - Dr. Mike Belkowski discusses the following: Intro: (0:00) Contraindications?: (2:27) BioLight's newest product The Glow: (5:27) Red light therapy and cancer: (12:45) Photobiomodulation research article: (13:31) Intro to the article out of the frontiers in oncology journal: (14:19) Photobiomodulation parameters: (17:27) Importance of consistent exposure: (22:17) LEDs for home use: (26:18) Light irradiance: (31:23) Red Light therapy and tumors: (35:58) Safety data: (37:44) Human clinical safety data: (39:38) Xerostomia and hyposalivation: (44:40) Bone necrosis: (48:40) Hand-foot syndrome: (49:08) Graft vs host disease: (49:29) Chemotherapy-induced alopecia: (50:59) Cancer treatment and quality of life: (52:29) - Research article from the episode:Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022 Learn more about RLT's benefits for: Cancer - Check out BioLight's newest device: the Glow! - Check out the Kindle version of Red Light Therapy Treatment Protocols eBook, 4th Edition - To learn more about red light therapy and shop for the highest-quality red light therapy products, visit https://www.biolight.shop - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Instagram YouTube Facebook

In this episode of BackTable ENT, Dr. Shah and Dr. Agan invite two comprehensive dentists, Dr. Abhishek Nagaraj and Dr. Anushka Gaglani, back to the show to discuss diagnosis and treatment of xerostomia. --- SHOW NOTES First, the doctors explain common causes of xerostomia, which include multiple medications and comorbid conditions. Lifestyle factors, such as mouth breathing, alcohol consumption, tobacco usage, smoking, and dehydration can also contribute to xerostomia. Less common causes of xerostomia include Sjogren syndrome, chemotherapy, radiation, and radioactive iodine exposure. Then, they discuss how to perform a comprehensive xerostomia workup. Xerostomia is formally diagnosed by measuring the rate of salivary flow for 5 minutes. It can also be diagnosed through minor salivary gland biopsy, but this procedure is performed by ENTs or oral surgeons, not dentists. After taking a thorough patient history, dentists may be able to see evidence of xerostomia during physical examination through signs like fissures on tongue, halitosis, ill-fitting dentures, and angular cheilitis. Then, the dentists explain the different treatments for xerostomia, from lifestyle changes to medications. They recommend that patients drink 60-65 ounces of water daily and brush at least two times a day. Fluoride mouthwashes and sugar-free lozenges may also help stimulate saliva production. Finally, a cholinergic medication like pilocarpine can be used if patients do not get better with non-pharmacologic intervention. Dr. Nagaraj also recommends that patients with xerostomia come in for dental cleaning four times a year instead of only twice because of their increased risk of developing dental caries. Finally, the doctors discuss how to distinguish the sensation of a dry mouth from the true diagnosis of xerostomia.

Kara Vavrosky, RDHEP, chatted with Dr. Mike Lynch, DMD, PhD, the Global Director of Scientific Engagement of Oral Health at LISTERINE®, about the role of alcohol in mouth rinses. The discussed some myths surrounding xerostomia, pH, and cancer risks of mouth rinses that contain alcohol.   To learn more about the safety of LISTERINE®, head on over to https://rdh.tv/ListerineSafety   This podcast episode is sponsored by LISTERINE®. Although LISTERINE® Antiseptic is the most extensively tested over-the-counter mouthrisnse in the world, with over 30 long-term clinical trials examining its safety and efficacy, there is still some misinformation out there over the uses of mouthrinses containing alcohol. To help understand the safety of alcohol-containing mouthrinses, in case any patients ask you about it, head on over to https://rdh.tv/ListerineSafety   Need CE? Start earning CE credits today at https://rdh.tv/ce  Get daily dental hygiene articles at https://www.todaysrdh.com Follow Today's RDH on Facebook: https://www.facebook.com/TodaysRDH/ Follow Kara RDH on Facebook: https://www.facebook.com/DentalHygieneKaraRDH/ Follow Kara RDH on Instagram: https://www.instagram.com/kara_rdh/

HOST: Dr. Jimmy Stewart, Professor of Internal Medicine and Pediatrics at the University of Mississippi Medical Center.TOPICS DISCUSSED: Dry mouth (Xerostomia), eye twitching, neuropathy (Neuritis), eczema (skin inflammation), burning mouth syndrome (Glossodynia), tennis elbow (Lateral Epicondylitis), Magnesium, B-12, B-3 and Vitamin D. EMAIL: remedy@mpbonline.orgIf you enjoyed listening to this podcast, please consider making a contribution to MPB: https://donate.mpbfoundation.org/mspb/podcast. Hosted on Acast. See acast.com/privacy for more information.

On this TIPisode Amber Auger, RDH talks to us about Xerostomia and the relief provided through GC America Dry Mouth Gel! Amber is a practicing hygienist, international Speaker and creator of Thrive in the Op TM!  Episode Highlights What is Xerostomia Long Term Relief Dry Mouth Gel  Quotes  “Most patients don't realize they have xerostomia."  “When our patients are struggling with xerostomia it can reduce their quality of life overall."  "Water only provides temporary relief." Links https://www.gcamerica.com/products/preventive/GC_Dry_Mouth_Gel/  http://www.gcamerica.com/ce/alleducation.php http://www.gcamerica.com   Amber Auger: https://www.instagram.com/amberaugerrdh/

On this TIPisode Amber Auger, RDH talks to us about Xerostomia and the relief provided through GC America Dry Mouth Gel! Amber is a practicing hygienist, international Speaker and creator of Thrive in the Op TM!  Episode Highlights What is Xerostomia Long Term Relief Dry Mouth Gel  Quotes  “Most patients don't realize they have xerostomia."  “When our patients are struggling with xerostomia it can reduce their quality of life overall."  "Water only provides temporary relief." Links https://www.gcamerica.com/products/preventive/GC_Dry_Mouth_Gel/  http://www.gcamerica.com/ce/alleducation.php http://www.gcamerica.com   Amber Auger: https://www.instagram.com/amberaugerrdh/

Download the Volley.FM app for more short daily shows!

On this episode of A Tale of Two Hygienists Andrew is joined in person at RDH Under One Roof by Brooke Crouch and guest co-host Erika Flateau, RDH! Brooke talks to us about Sjogren's, xerostomia and dry mouth sharing solutions she implements and recommends to her patients to find relief.    This episode has FREE CE (Coming Soon)! Be sure to view your state guidelines to ensure this CE is applicable in your State. You can view all episodes with Free CE here.   Episode Highlights  Meet Erika Sjogren's Essential Products    Quotes “When you are diagnosed with one autoimmune disorder you are 4x more likely to be diagnosed with another.”    “I've never had a cavity, ever, but I do all the things to prevent it.”    “Some people accept that they are going to lose their teeth, they think that is the progression of Sjogrens, but it doesn't have to be.”    “I give myself a fluoride varnish treatment every 3 months because I am high risk.”    “With low salivary flow you are not clearing food debris.”    “Most patients with dry mouth suffer from dry throat as well, which is tricky.”    Links   Erika's Email: erikaeksund@gmail.com    Brooke's Email: brookecrouchdentalconsulting@gmail.com 

On this episode of A Tale of Two Hygienists Andrew is joined in person at RDH Under One Roof by Brooke Crouch and guest co-host Erika Flateau, RDH! Brooke talks to us about Sjogren's, xerostomia and dry mouth sharing solutions she implements and recommends to her patients to find relief.    This episode has FREE CE (Coming Soon)! Be sure to view your state guidelines to ensure this CE is applicable in your State. You can view all episodes with Free CE here. Take the course for this episode here.   Episode Highlights  Meet Erika Sjogren's Essential Products    Quotes “When you are diagnosed with one autoimmune disorder you are 4x more likely to be diagnosed with another.”    “I've never had a cavity, ever, but I do all the things to prevent it.”    “Some people accept that they are going to lose their teeth, they think that is the progression of Sjogrens, but it doesn't have to be.”    “I give myself a fluoride varnish treatment every 3 months because I am high risk.”    “With low salivary flow you are not clearing food debris.”    “Most patients with dry mouth suffer from dry throat as well, which is tricky.”    Links   Erika's Email: erikaeksund@gmail.com    Brooke's Email: brookecrouchdentalconsulting@gmail.com 

On this Fast Facts: Pharmacology Edition Tom Viola, R. Ph., C.C.P. Tom talks to us about Xerostomia, commonly known as dry mouth highlighting solutions available for your patients. This series is sponsored by our friends at Elevate Oral Care! @elevateoralcare creates innovative and proven prevention-focused oral care products, learn more by visiting www.elevateoralcare.com and schedule your free CE staff-meeting today.

On this Fast Facts: Pharmacology Edition Tom Viola, R. Ph., C.C.P. Tom talks to us about Xerostomia, commonly known as dry mouth highlighting solutions available for your patients. This series is sponsored by our friends at Elevate Oral Care! @elevateoralcare creates innovative and proven prevention-focused oral care products, learn more by visiting www.elevateoralcare.com and schedule your free CE staff-meeting today.

When we think about salivary gland disorders, most dental hygienists will think about xerostomia. This is commonly the most noted chief complaint from our patients. Let's take a deep dive into the types of disorders that affect the salivary glands. They are not all cancerous, some are benign, and there are lots of things to know!Join Claire and Vickie Hawkins Schram to learn more about salivary gland disorders!

A falta de lubrificação bucal, a Xerostomia ou Hipossalivação, popularmente chamada de boca seca, atinge grande parte da população idosa, levando a problemas sérios de saúde. O problema pode ser provocado por uso de alguns medicamentos ou até pela diabetes ou outras doenças. Para falar sobre o assunto, Jota Batista conversa no Canal Saúde com a dentista Goretti Lima, Tutora do Curso de Odontologia da Faculdade Pernambucana de Saude-FPS.

Dry mouth impacts dental health in all aspects and can rapidly diminish the integrity of the dentition. Restorative work as well as periodontal health can be greatly impacted by xerostomia. The clinician should understand the role saliva has on the Dentition, how to spot xerostomia, and how to treat patients who suffer from xerostomia. Take a look at a recent product I tried and recommend. BRIO https://bit.ly/thehappyflosser Promo Code: HAPPYFLOSSER --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/billie43/message

This week on A Tale of Two Hygienists TIPisode we are joined by Brooke Crouch, RDH from Elevate Oral Care to talk to us about dry mouth and using Allday Dry Mouth Spray to treat your patients. Episode Highlights Causes of Dry Mouth Allday Dry Mouth Spray Xylitol  Quotes “Dry mouth is a subject I have become all too familiar with.”  “It isn't just our elderly patients that suffer from dry mouth.”  “That article said about 27% of people are suffering from dry mouth.”  “Recommending the right dry mouth product can not only alleviate their pain and discomfort but can also benefit their oral health.”  “Not all dry mouth sufferers are the same.”  Links Allday Dry Mouth Spray  Schedule AGD CE Accredited Staff Meeting 877-866-9113 or email info@elevateoralcare.com  Patient Centered Communication Video Series: http://www.elevateoralcare.com/elevatingcare Elevate Oral Care Website: http://www.elevateoralcare.com Elevate Oral Care Facebook: https://www.facebook.com/elevateoralcare Elevate Oral Care Instagram: https://www.instagram.com/elevate_oral_care/ More TIPisodes: https://www.ataleoftwohygienists.com/tipisodes/  AToTH Website: https://www.ataleoftwohygienists.com

This week on A Tale of Two Hygienists TIPisode we are joined by Brooke Crouch, RDH from Elevate Oral Care to talk to us about dry mouth and using Allday Dry Mouth Spray to treat your patients. Episode Highlights Causes of Dry Mouth Allday Dry Mouth Spray Xylitol  Quotes “Dry mouth is a subject I have become all too familiar with.”  “It isn't just our elderly patients that suffer from dry mouth.”  “That article said about 27% of people are suffering from dry mouth.”  “Recommending the right dry mouth product can not only alleviate their pain and discomfort but can also benefit their oral health.”  “Not all dry mouth sufferers are the same.”  Links Allday Dry Mouth Spray  Schedule AGD CE Accredited Staff Meeting 877-866-9113 or email info@elevateoralcare.com  Patient Centered Communication Video Series: http://www.elevateoralcare.com/elevatingcare Elevate Oral Care Website: http://www.elevateoralcare.com Elevate Oral Care Facebook: https://www.facebook.com/elevateoralcare Elevate Oral Care Instagram: https://www.instagram.com/elevate_oral_care/ More TIPisodes: https://www.ataleoftwohygienists.com/tipisodes/  AToTH Website: https://www.ataleoftwohygienists.com

While focused on dental applications like TMJ pain, xerostomia, and oral mucositis, this systematic review makes some very good points for light practitioners of any discipline. The researchers provide a look at the need to view deep tissue targeted laser therapy in tissue volume, rather than surface area. Dr. Rountree goes over the additional recommendations for proper spot size, energy dosing, and laser handpieces to achieve optimal tissue healing, whether the target is superficial or deep. Studies mentioned in this episode Photobiomodulation Dose Parameters in Dentistry: A Systematic Review and Meta-Analysis Further Resources:Success with Laser Therapy Flowchart & Checklist InfographicCheck out these FREE Provider ResourcesLearn more about what we offer on the LTI websiteFind out how you can Customize your LTI experienceRelated Podcast for PatientsHealing at the Speed of Light

An interview with Dr. Valeria Mercadante from University College London, Dr. Siri Beier Jensen from Aarhus University, and Dr. Douglas Peterson from UConn Health, authors on “Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.” This guideline provides evidence-based recommendations for interventions to prevent, minimize, and manage salivary gland hypofunction and xerostomia in patients receiving nonsurgical cancer therapy. Read the full guideline at www.asco.org/supportive-care-guidelines. Suggest a topic for guideline development at www.surveymonkey.com/r/ascoguidelinesurvey.   TRANSCRIPT [MUSIC PLAYING]   SPEAKER: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. [MUSIC PLAYING]   BRITTANY HARVEY: Hello, and welcome to the ASCO Guidelines Podcast Series brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all the shows, including this one, at podcasts.asco.org. My name is Brittany Harvey, and today I'm interviewing Dr. Valeria Mercadante from University College London and University College London Hospitals Trust in London, United Kingdom, Dr. Siri Beier Jensen from Aarhus University in Aarhus, Denmark, and Dr. Douglas Peterson from the School of Dental Medicine and Neag Comprehensive Cancer Center UConn Health in Farmington, Connecticut, authors on salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies, International Society of Oral Oncology, Multinational Association of Supportive Care in Cancer, and American Society of Clinical Oncology Guideline. Thank you for being here, Dr. Mercadante, Dr. Beier Jensen, and Dr. Petersen. VALERIA MERCADANTE: Thank you. It's a pleasure to be here. DOUGLAS PETERSON: Thank you. SIRI BEIER JENSEN: Thank you. BRITTANY HARVEY: First, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The full conflict of interest information for this guideline panel is available online with the publication of the guideline in the Journal of Clinical Oncology. Dr. Mercadante, do you have any relevant disclosures that are directly related to this guideline topic? VALERIA MERCADANTE: No, I do not have any relevant disclosure. BRITTANY HARVEY: Thank you. And Dr. Beier Jensen, do you have any relevant disclosures that are directly related to this guideline? SIRI BEIER JENSEN: No, I have no conflicts to declare related to this guideline topic. BRITTANY HARVEY: Thank you. And finally, Dr. Peterson, do you have any relevant disclosures that are related to this guideline topic? DOUGLAS PETERSON: No. No related conflicts to declare. BRITTANY HARVEY: Thank you. Then let's delve into some of the content of the guideline. First, Dr. Mercadante, can you give us an overview of this guideline's scope and purpose? VALERIA MERCADANTE: Of course. These clinical practice guidelines focus on the prevention and management of salivary gland hypofunction and xerostomia due to non-surgical cancer therapies. This is something we are deeply passionate about because nonsurgical cancer therapies, including all type of radiation regimens, chemotherapy, and biological cancer therapy, can damage the glands in our mouth that produce saliva, resulting in xerostomia, which we define as patient-reported subjective sensation of dryness and salivary gland hypofunction, which we define as reduced salivary flow rate as measured objectively. And this condition may last for several months or may become permanent. And because saliva serves so many important function, xerostomia may lead to a range of other symptoms that can impact patient quality of life. And therefore, ASCO, MASCC, and ISOO decided to update the findings of their two previous systematic reviews published in 2010 and provide a practical, evidence-based approach in a multidisciplinary testing to address this important topic. BRITTANY HARVEY: Great. Thank you for that background. So then I'd like to review the key recommendations of this guideline. This guideline covers two clinical questions, one on prevention and one on management. So Dr. Peterson, starting with prevention, what are the key recommendations regarding pharmacologic and non-pharmacologic interventions for the prevention of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies? DOUGLAS PETERSON: Thank you, Brittany. As you've noted, the guideline is framed in the context of two clinical questions, prevention and then followed by the management once the condition has occurred. Relative to prevention, there were eight recommendations, all of which were directed to reducing the risk of salivary gland hypofunction and/or xerostomia in patients with head and neck cancer. And as with other ASCO guidelines, each of these recommendations was in turn supported by text directed to literature review and analysis and clinical interpretation. So let me just briefly highlight the eight recommendations on prevention. Recommendation 1.1 was that intensity-modulated radiation therapy, IMRT, should be used to spare major and minor salivary glands from a higher dose of radiation. This was a very strong, well-evidenced recommendation. The evidence quality was high. The strength of the recommendation was strong. Recommendation 1.2 is that other radiation modalities that limit cumulative dose to an irradiated volume of major and minor salivary glands as one or more effectively than IMRT may be offered. Recommendation 1.3 reads that acupuncture may be offered during radiation therapy for head and neck cancer to reduce the risk of developing the symptom of xerostomia. Recommendation 1.4, systemic administration of the sialogogue bethanechol may be offered during radiation therapy for head and neck cancer. Recommendation 1.5-- and this is an important different type of recommendation-- vitamin E or other antioxidants should not be used to reduce the risk of chemoradiation-induced salivary gland hypofunction and xerostomia. And this is because of the potential adverse impact of these antioxidants on cancer-related outcomes and the lack of evidence of benefit. In addition to those five recommendations, there were three recommendations for which the evidence was insufficient. In the panel's view, it was important to delineate these three recommendations in the context of current clinical practice as well as opportunities for future research that we'll talk about in a little bit. The three recommendations for which there was insufficient evidence are 1.6. The panel was unable to make a recommendation for or against the use of submandibular gland transfer administered before head and neck cancer treatment. This limitation is due to the current amount of evidence associated with this surgical intervention, submandibular gland transfer, in relation to ever-evolving contemporary radiation modalities. Recommendation 1.7-- evidence remains insufficient for a recommendation for or against use of the following three interventions during radiotherapy for head and neck cancer. The three interventions are oral pilocarpine, amifostine in association with contemporary radiation modalities, and low-level laser therapy. And then, finally, recommendation 1.8-- the evidence remains insufficient for or against the use of several interventions, including selected radiation technology, for example, boost radiation or hyper or hypofractionated radiation therapy, Transcutaneous Electrical Nerve Stimulation or TENS, human epidermal growth factor, and selected complementary medicines. And again, the evidence is insufficient in the panel's view for a recommendation for or against these and several other interventions that are listed in the guideline. So I'll now turn the microphone back to Brittany. BRITTANY HARVEY: Great. Thank you for reviewing those prevention recommendations and explaining the evidence that supported those as well. That's very helpful. So following that, Dr. Beier Jensen, what are the key recommendations on pharmacologic and non-pharmacologic interventions for the management of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies? SIRI BEIER JENSEN: The key recommendations for the management of salivary gland hypofunction and xerostomia induced by cancer therapies are based on the principles of stimulation of the salivary reflex and lubrication of the oral tissues of, say, the mucosa and the teeth. The recommendations 2.2, 2.3, 2.4, and 2.5 address this stimulatory approach. If there is residual secretory capacity of the salivary glands, stimulation of natural saliva secretion may be provided by chewing or taste stimuli. This can be regular use of sugar-free lozenges, sugar-free candies, or sugar-free non-acidic chewing gum. In patients who has their natural teeth, it's important to be aware that if acidic candies are used to stimulate saliva secretion, then it should be a special nonerosive preparation for dentate patients that will say that they do not dissolve the tooth substance. Pharmacological stimulation is also an option by prescription medication such as oral pilocarpine and cevimeline in countries where this is available. This may result in systemic adverse effects that limit use in some patients. So the gustatory and masticatory salivary reflex stimulation, recommendation 2.2, the evidence-based quality was intermediate, and the strength of the recommendation was moderate. And for the pharmacological stimulation by pilocarpine and cevimeline, it was evidence-based, high-quality, and strong recommendation strength. For patients who have salivary gland hypofunction or xerostomia induced by radiation therapy for head and neck cancer, stimulation of saliva secretion may also be provided by acupuncture, transcutaneous electricity stimulation, or acupuncture-like transcutaneous electricity stimulation, although the evidence base here is less strong than for the other stimulatory management options mentioned. This is addressed in recommendation 2.4 and 2.5. If the residual secretory capacity of the salivary glands is low or maybe even nonexistent, then regular lubrication of the oral mucosa and teeth is of relevance. This is addressed in recommendation 2.1. Such lubrication may be provided by topical application of mucosal lubricants and saliva substitutes, which are agents directed at ameliorating xerostomia and other salivary gland hypofunction-related symptoms. It is important to notice that available stimulatory and lubricating options all provide transitory increased salivary flow rates and transitory relief from xerostomia. If you would like to review the specific recommendations, they can be found in the manuscript. BRITTANY HARVEY: Great. Thank you for reviewing those recommendations on the management of salivary gland hypofunction and/or xerostomia. So Dr. Peterson, you mentioned this earlier, but there are some cases in the guideline in which evidence was insufficient to make recommendations. And you went through a few of these areas. So what areas of future research did the panel discuss? DOUGLAS PETERSON: Thanks, Brittany. The panel worked very carefully to relate the quality of evidence to strength of each of the recommendations. In addition to providing important context regarding clinical prevention and treatment of xerostomia salivary hypofunction, novel directions for future research were therefore identified. And I'll just briefly delineate these future directions. Studies directed to the continued, rapidly-evolving radiation technology such as proton therapy and volumetric modulated art therapy or VMAT, as well as the length of time after this treatment is completed, for example, one to five years after completion of treatment, these studies are needed to assess the relationship of this rapidly-evolving technology to the long-term adverse oral events such as salivary gland hypofunction and xerostomia as well as advanced dental disease and osteoradionecrosis as well. Importantly, and the panel spent quite a bit of time deliberating this, ethical considerations must continue to be paramount in the study designs. And this is pertinent relative to this guideline. An important issue is that implementation of randomized clinical trials comparing current and novel radiation therapy modalities is typically precluded for ethical reasons. So this is a barrier to address, and the panel wanted to call attention to the scientific and clinical community. In addition to the radiation technology itself, two additional future research directions also represent potential strategic advances in the field as well. First, radiosensitivity of parotid gland stem cells. For example, it has been recently shown that not all constituents of the parotid gland are equally radiosensitive because of an unequal distribution of the stem cells within the gland. This and related biologic concepts should be incorporated in future randomized controlled trials of head and neck cancer patients. Secondly, novel regenerative medicine options may be used to spare, optimize, or restore salivary gland function after treatment. The guideline addresses these innovative treatment approaches in the context of both the current state of the science as well as opportunities for future research. I'll turn the microphone back to Brittany. BRITTANY HARVEY: Great. Thank you, Dr. Peterson, for reviewing those areas where additional research would be helpful. So next, in your view, Dr. Mercadante, what is this guideline's importance and how will it affect clinicians? VALERIA MERCADANTE: Thank you for this question. We believe these guidelines offers an opportunity for any clinician involved in non-surgical cancer therapies-- oncologists, dentists, dental specialist, dental hygienists, oncology nurses, clinical researchers, advanced practitioner. We all have an essential role in supporting our patient for the entire journey by optimizing symptoms management and improve our patient quality of life. These guidelines thus suggest a preventative and treatment course, but we've also delineated what we feel is common practice between expert and what areas would need further research to provide, as Dr. Peterson beautifully described, an ethical framework for future studies in this field. BRITTANY HARVEY: Great. Thank you so much. So finally, Dr. Beier Jensen, how will these guideline recommendations impact patients? SIRI BEIER JENSEN: Well, for patients who live with these complications during cancer treatment or as [INAUDIBLE] of cancer therapies, these guideline recommendations on prevention and management of salivary gland hypofunction and xerostomia will enable them evidence-based and with the help of professional health care providers to support the natural functions of saliva and promote their oral comfort and health. BRITTANY HARVEY: Great. Well, thank you all, Dr. Mercadante, Dr. Beier Jensen, and Dr. Peterson for taking the time to work on this guideline and produce evidence-based recommendations for clinicians and patients. And thank you for taking the time to speak with me today. VALERIA MERCADANTE: Thank you. DOUGLAS PETERSON: Thank you. BRITTANY HARVEY: And thank you to all of our listeners for tuning into the ASCO Guidelines podcast series. To read the full guideline, go to www.asco.org/supportive care guidelines. Additionally, our annual survey for guideline topics is open for submissions. Suggest a topic for guideline development at SurveyMonkey.com /r/ascoguidelinesurvey by August 1st. The link is also available in the episode notes of this podcast. If you've enjoyed what you've heard today, please rate and review the podcast, and be sure to subscribe so you never miss an episode. [MUSIC PLAYING]

Dental podcast: Welcome to DentalTalk. I'm Dr. Phil Klein. Today we'll be discussing the varying degrees of xerostomia and their effects on a person's oral health. We will discuss the range of solutions available for this condition which are designed to increase patient comfort and ultimately improve quality of life. Our guest is Brooke Crouch, a dental hygienist with over a decade of clinical experience. Brooke is a key opinion leader, author, national speaker, and above all, patient advocate. Brooke is passionate about educating dental professionals on the effects of xerostomia and speaks from both a provider and patient perspective.

A sensação de estar com mau hálito, por si só, já causa uma apreensão enorme. Agora, já imaginou conviver com esse problema diariamente? Ter mau hálito pode ser bastante difícil para quem sofre com a condição, que tem nome e causas específicas: halitose.  Em entrevista ao programa Momento Odontologia desta semana, o professor Vinícius Pedrazzi, da Faculdade de Odontologia de Ribeirão Preto (Forp) da USP, explicou que “a halitose é um sinal de má higiene oral ou de algo errado no organismo”.  Causas do mau hálito O professor contou que antigamente acreditava-se que as maiores causas de halitose estavam relacionadas ao aparelho digestivo ou ao trato respiratório superior, mas que “hoje já se sabe que cerca 95% das causas são bucais”.  Entre as principais causas estão a saburra lingual, que é o biofilme que fica no dorso da língua; a doença periodontal; alimentos em decomposição entre os dentes; causas sistêmicas, como sinusite, problemas nas vias respiratórias ou até mesmo refluxo.  “Mas a maior parte das causas é a de sujeiras no dorso da língua, doença periodontal, doenças de gengiva e falta do uso de fio dental, provocando decomposição de alimentos”, resume Pedrazzi.  Sintomas  Além do mau hálito, a halitose pode ter outros sintomas ou sinais. “Um deles é a boca seca”, explica Pedrazzi. Além disso, a sensação de garganta colando e dificuldade em falar também podem ser indicativos.  E a halitose pode trazer ainda mais problemas, caso suas bactérias não sejam removidas do dorso da língua. “Algumas bactérias podem ser deglutidas, o que pode levar esse biofilme até os pulmões, chegar nos brônquios e provocar uma pneumonia por aspiração.”  Tratamento O tratamento pode ser bem simples e, na maioria dos casos, se resume a melhorar a higiene bucal, com uso de fio dental e higienizador de língua. Já em casos como uma doença periodontal, o tratamento envolve uma cirurgia.  Pedrazzi explica que o dentista também pode recomendar uma grande ingestão de água para o paciente, o que pode ser muito importante. Isso porque a xerostomia, popularmente conhecida como boca seca, “provoca mau hálito pela decomposição de alimentos, micro-organismos e também células epiteliais descamadas”.  Mas se o problema persistir mesmo com o tratamento, o paciente deve procurar um cirurgião-dentista. Caso o problema não seja resolvido, ele poderá ser encaminhado para um médico do trato respiratório, como um otorrinolaringologista ou gastroenterologista.  Pedrazzi ainda dá uma dica para saber qual o possível causador da halitose. “O paciente deve usar enxaguante bucal por cerca de uma semana, a cada refeição. Se o problema melhorar, diminuir ou até mesmo desaparecer, a causa é bucal.”   Momento Odontologia Produção e Apresentação: Rosemeire Talamone CoProdução: Alexandra Mussolino de Queiroz (FORP), Letícia Acquaviva (FO),

A sensação de estar com mau hálito, por si só, já causa uma apreensão enorme. Agora, já imaginou conviver com esse problema diariamente? Ter mau hálito pode ser bastante difícil para quem sofre com a condição, que tem nome e causas específicas: halitose.  Em entrevista ao programa Momento Odontologia desta semana, o professor Vinícius Pedrazzi, da Faculdade de Odontologia de Ribeirão Preto (Forp) da USP, explicou que “a halitose é um sinal de má higiene oral ou de algo errado no organismo”.  Causas do mau hálito O professor contou que antigamente acreditava-se que as maiores causas de halitose estavam relacionadas ao aparelho digestivo ou ao trato respiratório superior, mas que “hoje já se sabe que cerca 95% das causas são bucais”.  Entre as principais causas estão a saburra lingual, que é o biofilme que fica no dorso da língua; a doença periodontal; alimentos em decomposição entre os dentes; causas sistêmicas, como sinusite, problemas nas vias respiratórias ou até mesmo refluxo.  “Mas a maior parte das causas é a de sujeiras no dorso da língua, doença periodontal, doenças de gengiva e falta do uso de fio dental, provocando decomposição de alimentos”, resume Pedrazzi.  Sintomas  Além do mau hálito, a halitose pode ter outros sintomas ou sinais. “Um deles é a boca seca”, explica Pedrazzi. Além disso, a sensação de garganta colando e dificuldade em falar também podem ser indicativos.  E a halitose pode trazer ainda mais problemas, caso suas bactérias não sejam removidas do dorso da língua. “Algumas bactérias podem ser deglutidas, o que pode levar esse biofilme até os pulmões, chegar nos brônquios e provocar uma pneumonia por aspiração.”  Tratamento O tratamento pode ser bem simples e, na maioria dos casos, se resume a melhorar a higiene bucal, com uso de fio dental e higienizador de língua. Já em casos como uma doença periodontal, o tratamento envolve uma cirurgia.  Pedrazzi explica que o dentista também pode recomendar uma grande ingestão de água para o paciente, o que pode ser muito importante. Isso porque a xerostomia, popularmente conhecida como boca seca, “provoca mau hálito pela decomposição de alimentos, micro-organismos e também células epiteliais descamadas”.  Mas se o problema persistir mesmo com o tratamento, o paciente deve procurar um cirurgião-dentista. Caso o problema não seja resolvido, ele poderá ser encaminhado para um médico do trato respiratório, como um otorrinolaringologista ou gastroenterologista.  Pedrazzi ainda dá uma dica para saber qual o possível causador da halitose. “O paciente deve usar enxaguante bucal por cerca de uma semana, a cada refeição. Se o problema melhorar, diminuir ou até mesmo desaparecer, a causa é bucal.”   Momento Odontologia Produção e Apresentação: Rosemeire Talamone CoProdução: Alexandra Mussolino de Queiroz (FORP), Letícia Acquaviva (FO), Paula Marques e Tiago Rodella (FOB) Edição Sonora: Gabriel Soares Edição Geral: Cinderela Caldeira E-mail: ouvinte@usp.br Horário: segunda-feira, às 8h05 Você pode sintonizar a Rádio USP em São Paulo FM 107,9; ou Ribeirão Preto FM 107.9, ou pela internet em www.jornal.usp.br ou pelo aplicativo no celular para Android e iOS   Veja todos os episódios do Momento Odontologia     .

Download the Volley.FM app for more short daily shows!

Xerostomia and Periodontal Disease: How to Customize Your Treatment Approaches By Meghan Greening, RDH, BSDH, EFDA Original article published on Today's RDH: https://www.todaysrdh.com/xerostomia-and-periodontal-disease-how-to-customize-your-treatment-approaches/ Get daily dental hygiene articles at https://www.todaysrdh.com Follow Today's RDH on Facebook: https://www.facebook.com/TodaysRDH/ Follow Kara RDH on Facebook: https://www.facebook.com/DentalHygieneKaraRDH/ Follow Kara RDH on Instagram: https://www.instagram.com/kara_rdh/

In this sponsored episode, Matthew sits down with his friends to talk all about the glamorous issue of Xerostomia, otherwise known as "Dry Mouth."This is a problem for millions of Americans, but no one talks about it. Why don’t we talk about it? Maybe it’s because when your mouth is dry, talking is the last thing you want to do. There are way too many causes of dry mouth, such as stress & anxiety, cancer treatment, antihistamines, menopause, alcohol or cannabis, vaping, coffee, and nearly every prescription medication on the market. Introducing Moisyn for dry mouth relief.Not only does Moisyn work, but it’s Clinically Proven, Dentist- Recommended, Naturally Derived, Non-Toxic, and long-lasting. It freshens your breath, and it’s made in the USA. So what else do you need to know? it’s clearly time for all of us to Moisyn Up and make dry mouth suck less. Head on over to DryMouthSucks.com and save 15% off your order. No coupon code needed. The Discount will be automatically applied at checkout. That’s DryMouthSucks.com

Dr. Cameron feels that the best way to get to know Lyme disease is through reviewing actual cases. In this Inside Lyme Podcast episode, he will be discussing a 43-year-old woman with Sjögren’s syndrome secondary to Lyme diseaseSmiyan and her colleague first discussed this case in the journal Reumatologia in 2019.This woman’s diagnosis was changed from possible Lymphoma to primary Sjögren’s syndrome, to secondary Sjögren’s syndrome. You can hear more about these cases through his blogs, social media, and YouTube. Sign up for our newsletter to keep up with these cases.You can read the full text of this podcast at: https://danielcameronmd.com/lyme-podcast-sjogrens-syndrome-secondary-to-lyme-disease/How to Connect with Dr. Daniel Cameron:Check out his website: https://www.DanielCameronMD.com/Call his office: 914-666-4665Email him: DCameron@DanielCameronMD.com Send him a request: https://danielcameronmd.com/contact-daniel-cameron-md/Like him on Instagram: https://www.instagram.com/drdanielcameron/Join his Facebook group: https://www.facebook.com/danielcameronmd/Follow him on Twitter: https://twitter.com/DrDanielCameronSign up for his newsletter: https://www.DanielCameronMD.com/Subscribe and ring the bell: https://www.youtube.com/user/danielcameronmd/ Leave a review on iTunes or wherever else you get your podcasts.We, of course, hope you’ll join the conversation, connect with us and other readers, ask questions, and share your insights. Dr. Cameron is a Lyme disease expert and the author "Inside Lyme: An expert's guide to the science of Lyme disease." He has been treating adolescents and adults for more than 30 years.Please remember that the advice given is general and not intended as specific advice as to any particular patient. If you require specific advice, then please seek that advice from an experienced professional.

Dry Mouth is not only a very uncomfortable condition, but it could also be affecting your dental health and your overall wellness. Find out how you can remedy this problem on today's episode of This Old Tooth.

Jason and Alan are joined by two dental social media rock stars, Dr. David Rice of IgniteDDS and Irene Iancu (aka: toothlife.irene) of the Tooth or Dare podcast! David knows young dentists. He's an educator and coach and spends a lot of his time helping new dentists find their way after dental school. His message is a lot more hopeful than what you hear from some people and his reach is really huge! David also spent some time talking about 3M's new Xerostomia Relief Spray. Dentistry hasn't done a great job for our patients with dry mouth and 3M has made a product that can really make a difference for them! Irene Iancu is a hygienist, educator, social media maven and entrepreneur! She's got a great podcast called "Tooth or Dare" and she'll be podcasting live at the Voices of Dentistry with her new co-host. She's fascinating on a lot of levels, but we spent a lot of time explaining how she, as a hygienist, is opening a dental practice! If you've ever wondered how a dental practice owned by a "nondentist" can work, this is really interesting stuff! Apparently delays in dental office building affect everyone! Some links from the show: It's time to sign up for VoD (January 24-25th at the Hilton Scottsdale Resort and Villas The Voices of Dentistry is just over two months away! We have an amazing speaker line up, some very exciting exhibitors and the best party in all of dentistry! Go check it out and register at www.voicesofdentistry.com! VoD 2019 Highlight video Vote for the Dental Hacks for "Favorite Dental Podcast of 2019!" The Dental Hacks Nation closed Facebook group has 28,000 members! Head over there to interact with other Dental Hacks listeners, guests and Brain Trust members every day, all day! Remember…if you don’t have anything “dental” on your FB page, we might decline your membership request. So IM the group or email us at info@dentalhacks.com! YAPI can help make all of your holiday dreams come true! Jason was dreaming of smooth and effortless front desk efficiency and a giant YAPI puppy explained how his dreams could be reality! Go get your own YAPI puppy by getting a demo at dentalhacks.com/YAPI. It’s a funny name but serious software! Go Hack Yourself Alan: Steelmade USA flat top grill If you have any questions or comments for us please drop us an email at info@dentalhacks.com or find us (and like us!) at www.facebook.com/dentalhacks. Or, if you prefer…give us a call at (866) 223-5257 and leave us a message. You might be played in the show! If you like us, why not leave us a review on iTunes? It helps us get found by like minded people and might even help us get into “What’s Hot” in the iTunes store! Go to this link and let the world know about the Dental Hacks! Finally, if you aren’t an Apple person, consider reviewing us on Stitcher at: stitcher.com/podcast/the-dentalhacks-podcast! If you would like to support the podcast you can check out our Patreon page! Although the show will always remain free to download, our Patreon supporters get access to special bonus content including (at least) one extra podcast episode every months! Also be sure to check out the Dental Hacks swag store where you can find t-shirts, stickers coffee mugs and all sorts of other things that let the world know you’re a part of the Hacks Nation.  

  Welcome to another episode of Tooth or Dare with Podcast!  WE NEED YOUR VOTES Please click here to vote for us as the 2019 podcast of the year!  This week Irene has dedicated this episode to Emily Boge! She's amazing!  @Joycethedentist is amazing, Started her Instagram to grow her beautiful practice and since then has started a vlog, created an e-book for dentists AND now has a cute TikTok account!  Visit her Instagram RIGHT HERE to follow her and read her feature in Incisal Edge Magazine as she made 40 under 40 in dentistry!  Huge thanks to 3M for Sponsoring this week’s episode and giving us a cool spot to record live at CDA!This week's product spotlight was developed to help patients who suffer from xerostomia. Irene wrote a cool scientific article in the Dental Economics Magazine in the November Issue that talks all about early identification of dry mouth and salivary gland dysfunction.  3M offers a suite of products to tackle xerostomia from multiple angles. First, there is the 3M Xerostomia Relief Spray, which is a lipid-based solution designed to limit water loss, moisten, and lubricate the entire oral cavity. This is a prescription product that can be dispensed directly out of the office or your doctor can write a prescription and send it directly to a specialty pharmacy. Many patients like to use Theramints, which are 100% xylitol-sweetened mints to stimulate their saliva throughout the day. I strongly recommend high-risk patients have an in-office varnish with Vanish 5% sodium fluoride white varnish can be used every 3 to 6 months. Helps with sensitivity relief by releasing fluoride, calcium and phosphate for up to 24 hours.  Lastly send a patient home with Clinpro 5000, a high-fluoride toothpaste, containing their patented functionalized tri-calcium phosphate. This can be prescribed for patients to use at least once a day for caries prevention. To learn more about 3M’s suite of products to help with xerostomia, like Clinpro 5000, Theramints, Vanish Varnish and Xerostomia Relief Spray visit 3M.com/Xerostomia  

Dr. Porter Jones founded and was CEO of Dr. Porto, a chain of medical and dental clinics in Sao Paulo focused on providing high value patient care to the medically underserved. Prior, Dr. Jones spent 4 years at Hospital Albert Einstein where he managed the oncology department as well as the medical practice division. He currently is the CEO of Boka Sciences, an oral health company focused on preventative care through the diagnosis, monitoring and treatment of xerostomia. Dr. Jones is a graduate of the University of Utah School of Medicine and has an MBA from Harvard Business School.

This week in Dental news to abuse will start off by discussing how  dental offices can win back lost patience as well we'll talk about a new retraction paste that's made out of a combination of 15% aluminum chloride and kaolin Clay will also discuss  a new product available called Moisyn they can help patients with xerostomia or dry mouth. I will also talk about an implant post-operative care system and a handheld intraoral x-ray system and a new water line filter guaranteed to keep your water lines clean and bacteria free.

(Cápsula 005) Efectos de la hidroxicloroquina en la mejoría sintomática del Síndrome de Sjögren primario. Enlace: https://www.ncbi.nlm.nih.gov/pubmed/?term=sjogren+joquer

(Cápsula 006) Comentamos generalidades sobre el Síndrome de Sjögren.

Todd McNutt, Ph. D, author of an article recently published in Advances, shares the process and results of using machine learning methods to identify dose patterns that predict for xerostomia in head and neck cancer patients. Dr. McNutt identifies the advantages and challenges inherent in utilizing this newer method rather than more traditional predictors. Advances associate senior editor, Matthew Studenski, Ph. D provides perspective on the growing use of machine learning and AI in medical research. Music by D. Tegbaru, used with permission.

Xerostomia é definida como uma sensação de boca seca e pode estar relacionado à diversos fatores locais e ainda ser um sinal para doenças mais graves.

Xerostomia is a condition also known as Dry Mouth and is usually caused by taking medication or smoking tobacco. There are treatments available in the form of prescription medication or an oral rinse.

Leo shares with us "Moisyn". Free of harsh chemicals and other things that you see in many of the products on the market and is a great treatment for Dry Mouth.

Como identificar e tratar pacientes com Xerostomia? Nesse episódio, vamos falar desse tema tão recorrente na prática clínica do dentista. ------------------------------------ Se você ainda não ouve no Iphone ou Android, veja como fazer: IPHONE 1-Clicar no ícone do aplicativo Podcast (já vem instalado no IPHONE) 2-Clicar em “Buscar” 3-Digitar “Odontologia Cast” 4- Clicar em “Assinar” ANDROID 1- Baixar o aplicativo gratuito “Podcast Addict” 2- Procurar por “Odontologia Cast” 3- Assinar o podcast ------------------------------------

Talking about Xerostomia, also known as dry mouth and dry mouth syndrome

Ayer, 4 de Febrero fue el Día Mundial del Cáncer y de ello trata este podcast. El cáncer es un crecimiento y diseminación incontrolados de células malignas. Puede darse en cualquier órgano y si afectara también al tejido circundante, se produciría lo que se conoce como metástasis. En España hay cada año más de 250.000 nuevos casos de cáncer diagnosticados.Hay diferentes tipos:- Carcinomas: Son los más comunes, los que afectan a los órganos.- Sarcomas: Aquellos que se crean a partir del tejido conectivo: músculos, huesos, cartílagos, tejido graso.- Leucemias: En la médula ósea.- Linfomas: En el tejido linfático: ganglios y órganos linfáticos. Sin embargo, no todos los tumores son malignos, hay algunos benignos que no se diseminan, por lo tanto si encontramos un tumor en nuestro cuerpo, lo mejor es acudir a un médico. Los factores de riesgo son:- Índice de masa corporal elevado- Consumo de alcohol- Fumar- Baja ingesta de frutas y verduras- Baja actividad físicaEn cuanto a la dieta, la dieta anticáncer no existe pero si que se puede llevar una dieta de prevención:- Alta ingesta de frutas y verduras: una ración abundante en cada comida principal y frutas entre horas.- Alta ingesta de fibra dietética: cereales integrales, legumbres, frutos secos.- Baja ingesta de carnes procesadas, incluido el jamón serrano o ibérico.- Baja ingesta de azúcar.- No beber alcohol, cero. - Controlar el peso, con un IMC entre 20 y 25. - Ser activo y practicar algún deporte o actividad física. Algunas de las consecuencias del tratamiento con radio o quimioterapia son:- Anorexia: pérdida del apetito.- Náuseas y vómitos.- Diarreas.- Estreñimiento.- Xerostomia: sequedad de boca.- Mucositis: inflamación de la mucosa de la boca.- Disfagia: dificultad para tragar.- Disgeusia: alteración de los sabores. Página web: www.comiendoconmaria.comSuscríbete a los cursos: www.comiendoconmaria.com/cursosEnvía tu pregunta para el podcast mensual de “preguntas de los oyentes” a info@comiendoconmaria.com o https://www.comiendoconmaria.com/contacta/También me encontrarás en redes sociales:Facebook: www.facebook.com/comiendoconmariaInstagram: www.instagram.com/comiendoconmaria_OficialTwitter: https://twitter.com/comiendo_mariaPinterest: https://www.pinterest.es/comiendoconmaria

Ayer, 4 de Febrero fue el Día Mundial del Cáncer y de ello trata este podcast. El cáncer es un crecimiento y diseminación incontrolados de células malignas. Puede darse en cualquier órgano y si afectara también al tejido circundante, se produciría lo que se conoce como metástasis. En España hay cada año más de 250.000 nuevos casos de cáncer diagnosticados.Hay diferentes tipos:- Carcinomas: Son los más comunes, los que afectan a los órganos.- Sarcomas: Aquellos que se crean a partir del tejido conectivo: músculos, huesos, cartílagos, tejido graso.- Leucemias: En la médula ósea.- Linfomas: En el tejido linfático: ganglios y órganos linfáticos. Sin embargo, no todos los tumores son malignos, hay algunos benignos que no se diseminan, por lo tanto si encontramos un tumor en nuestro cuerpo, lo mejor es acudir a un médico. Los factores de riesgo son:- Índice de masa corporal elevado- Consumo de alcohol- Fumar- Baja ingesta de frutas y verduras- Baja actividad físicaEn cuanto a la dieta, la dieta anticáncer no existe pero si que se puede llevar una dieta de prevención:- Alta ingesta de frutas y verduras: una ración abundante en cada comida principal y frutas entre horas.- Alta ingesta de fibra dietética: cereales integrales, legumbres, frutos secos.- Baja ingesta de carnes procesadas, incluido el jamón serrano o ibérico.- Baja ingesta de azúcar.- No beber alcohol, cero. - Controlar el peso, con un IMC entre 20 y 25. - Ser activo y practicar algún deporte o actividad física. Algunas de las consecuencias del tratamiento con radio o quimioterapia son:- Anorexia: pérdida del apetito.- Náuseas y vómitos.- Diarreas.- Estreñimiento.- Xerostomia: sequedad de boca.- Mucositis: inflamación de la mucosa de la boca.- Disfagia: dificultad para tragar.- Disgeusia: alteración de los sabores. Página web: www.comiendoconmaria.comSuscríbete a los cursos: www.comiendoconmaria.com/cursosEnvía tu pregunta para el podcast mensual de “preguntas de los oyentes” a info@comiendoconmaria.com o https://www.comiendoconmaria.com/contacta/También me encontrarás en redes sociales:Facebook: www.facebook.com/comiendoconmariaInstagram: www.instagram.com/comiendoconmaria_OficialTwitter: https://twitter.com/comiendo_mariaPinterest: https://www.pinterest.es/comiendoconmaria

Indu Ambudkar explains why radiation therapy for head and neck cancers causes dry mouth.

MighTeaFlow® lozenges (Nomax Inc, St. Louis, MO, USA) containing 2 plant extracts including green tea catechins with 500 mg xylitol compared to xylitol alone taking 1 lozenge every 4 hours with a maximum of 6 lozenges per day showed after Continue reading Dry Mouth (Xerostomia) Helped with Natural Formula Containing Green Tea Catechins – An Interview with Stephen Hsu, PhD→ The post Dry Mouth (Xerostomia) Helped with Natural Formula Containing Green Tea Catechins – An Interview with Stephen Hsu, PhD appeared first on .

Dr. Paula Friedman is a Professor in the Department of General Dentistry in the Harry M. Goldman School of Dentistry at Boston University. A specialist in geriatric dentistry, her research interests focus on health services and specifically on increasing access to oral health care for underserved populations. Activities include conducting oral health screenings for community-based, independently living elders; facilitating oral health in-home consultations for frail, home-bound elders; and assessing levels of satisfaction with services received by student dental plan members. Her research interests also include studying barriers to oral health services as perceived by underserved populations. Dr. Friedman's publications have addressed issues pertaining to the management of elderly diabetic patients and also have focused on Xerostomia, the "invisible" oral health condition. Her doctor of dental science degree is from Columbia University and she also obtained two masters degrees at Boston University, including one in public health. In this interview, Dr. Friedman discusses common ailments in oral health in the elder population as well as ageism, interprofessional care, and other critical elements of this subject.